Why Did Plexus (PLXS) Move Today?

Simply Wall St

Plexus (PLXS) drew attention after director Karen Marie Rapp sold 500 shares on August 31, 2026, under a Rule 10b5-1 plan while retaining 7,535 shares in the company.

Recent trading reflects that mixed picture. Plexus has risen 3.4% on a 1-day share price return and 3.8% over the past week, even though the 30-day share price return is down 4.5% and the 90-day share price return is down 13.5%. At the same time, a 1-year total shareholder return of 85.0% and a 3-year total shareholder return of about 1.8x suggest longer term momentum has been strong despite the recent pullback.

Scan beyond Plexus and see how it stacks up against a curated group of financially solid peers using our list of solid balance sheet and fundamentals (23 results) for potential next ideas.

Plexus has pulled back in the short term while longer term holders still sit on strong gains. Does that price reset leave more upside for new buyers, or does it skew the risk toward late entrants?

Most Popular Narrative: 16% Undervalued

Plexus is trading at $255.34 while the most followed narrative pegs fair value at $305.75, so the gap rests in expectations for future contracts, margins and cash returns to shareholders rather than today’s earnings alone.

The company's increasing success in winning programs in high-margin, complex sectors such as healthcare/life sciences, aerospace, and defense (including strong defense pipeline in Europe and record sector wins), is shifting the revenue mix toward segments with higher pricing power and more stable, long-term contracts. This should positively impact both revenue consistency and net margin expansion.

See why 1 investors see Plexus as 16% undervalued.

Result: Fair Value of $305.75 (UNDERVALUED)

Still, Plexus carries real execution risk if large customers slow orders or if new facilities and share buybacks fail to deliver the expected earnings uplift.

Find out about the key risks to this Plexus narrative.

Another View On Plexus Valuation

The DCF work suggests Plexus trades about 3.9% below an estimated fair value of $265.74, so the margin of safety looks slim compared with the 16% narrative gap. That raises a simple question for investors: Is the story premium worth paying for when the cash flow model is more restrained?

To see how this cash flow based view is built and what would need to change for a wider discount or premium, Look into how the SWS DCF model arrives at its fair value.

PLXS Discounted Cash Flow as at Sep 2026

Next Steps

Sentiment around Plexus is mixed, and the only way to cut through the noise is to review the data yourself and move quickly while prices settle. For more insight into which rewards investors are focusing on, check out the 3 key rewards

Looking For More Investment Ideas Beyond Plexus?

Do not stop with Plexus. Broaden your watchlist using idea lists that surface different kinds of opportunities investors often overlook until the move is already underway.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Plexus might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com